Skip to main content

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Viatris, Canopy Growth, and Everus and Encourages Investors to Contact the Firm

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Viatris Inc. (NASDAQ: VTRS), Canopy Growth Corporation (NASDAQ: CGC), and Everus Construction Group, Inc. (NYSE: ECG). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Viatris Inc. (NASDAQ: VTRS)

Class Period: August 8, 2024 - February 26, 2025

Lead Plaintiff Deadline: June 3, 2025

The Complaint alleges that Defendants provided investors with material information concerning the failed inspection of Viatris' Indore, India facility. Specifically, the Complaint alleges that Defendants' statements misrepresented the FDA's issuance of a warning letter and its impact on Viatris' operations and that Defendants routinely referred to the impact of the warning letter as a mere "minor headwind" for the Company.

For more information on the Viatris class action go to: https://bespc.com/cases/VTRS

Canopy Growth Corporation (NASDAQ: CGC)

Class Period: May 30, 2024 - February 6, 2025

Lead Plaintiff Deadline: June 3, 2025

According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Canopy Growth had incurred significant costs producing Claybourne Co. ("Claybourne") pre-rolled joints in connection with the Claybourne product launch in Canada; (2) the foregoing costs, in addition to certain indirect costs that Canopy Growth incurred in connection with its Storz & Bickel vaporizer devices, were likely to have a significant negative impact on the Canopy Growth's gross margins and overall financial results; (3) accordingly, defendants had overstated the efficacy of Canopy Growth's cost reduction measures and the health of its gross margins while downplaying issues with the same; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Canopy Growth class action go to: https://bespc.com/cases/CGC

Everus Construction Group, Inc. (NYSE: ECG)

Class Period: October 31, 2024 - February 11, 2025

Lead Plaintiff Deadline: June 3, 2025

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors that: (1) the Company's backlog conversion cycle had become elongated due to larger, more complex projects; (2) as a result, the Company's revenue recognition would be delayed; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

For more information on the Everus class action go to: https://bespc.com/cases/ECG

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.